Greiner Bio-One North America, Inc. Announces New Product for the Stabilization of Urine Specimens

MONROE, N.C.–(BUSINESS WIRE)–#hospital–To provide an optimal solution for urine diagnostics, Greiner Bio-One
has developed the new VACUETTE®
Urine CCM Tube
. The evacuated tube contains a powdered additive,
which keeps the urine sample stable for up to 48 hours at room
temperature. During this time period, the urine specimen can be stored
or transported without refrigeration that would otherwise be required.
The product is also manufactured with a safety cap that is leak proof
yet easy to open allowing for a hygienic operating method, with no risk
of the splashes or aerosols that can occur with a standard stopper. In
addition, it is made from highly transparent PET plastic making it
virtually unbreakable.


Reliable results can only be achieved in urine diagnostics if the
correct preanalytical conditions are ensured. Urine collection, specimen
transport, and further storage are critical factors for sample quality
and can affect the results. Most important is the stabilization of
urine, if the specimen cannot be analyzed within two hours(1).
A particular problem is exponential bacterial growth, since certain
bacteria divide every 20 minutes. This can lead to an overgrowth of
pathogenic bacteria, making detection difficult. This problem can lead
to inaccurate results particularly with longer transportation and
processing times. It has been shown, that on average 15% of urine
samples intended for urine culture are contaminated.(2)

The VACUETTE®
Urine CCM Tube
preserves specimen integrity and is therefore ideal
for transport and processing of urine samples for microbiology culture.

Greiner Bio-One North America, Inc. is a privately held plastic
manufacturing company located in Monroe, NC whose three divisions
manufacture a variety of products for the medical and research fields.
The manufactured products include plastic ware for the cultivation and
analysis of cell and tissue cultures, microplates for high-throughput
screening related to drug screening, products for blood and specimen
collection, tests for the detection of bacteria and viruses, as well as,
custom-made products. As an international manufacturer with global
reach, Greiner Bio-One provides the manufacturing, distribution
logistics and product application support to the world’s largest
hospitals, pharmaceutical and biotechnology corporations.

For more information about Greiner Bio-One North America, Inc., please
visit http://www.gbo.com.

      1)     CLSI. Urinalysis; Approved Guideline – Third Edition. GP16-A3. Vol
29 No 4.
2)

Berkeris LG Jones BA Walsh MK and Wagar EA: Urine Culture
Contamination: A College of American Pathologists Q-Probes Study
of 127 Laboratories, Arch Pathol Lab Med. 2008 132(6):913-917

Contacts

Greiner Bio-One North America, Inc.
Mackenzie Farone-Waite,
704-261-7860
[email protected]